title: Antithrombotic therapies for sepsis: a need for more studies.
authors.forename: Peter C
authors.initials: PC
authors.lastname: Minneci
authors.forename: Katherine J
authors.initials: KJ
authors.lastname: Deans
authors.forename: Xizhong
authors.initials: X
authors.lastname: Cui
authors.forename: Steven M
authors.initials: SM
authors.lastname: Banks
authors.forename: Charles
authors.initials: C
authors.lastname: Natanson
authors.forename: Peter Q
authors.initials: PQ
authors.lastname: Eichacker
mesh_terms: D000990:Antithrombin III / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use*; D016019:Survival Analysis
chemical_list: D005343:Fibrinolytic Agents; D015842:Serine Proteinase Inhibitors; D000990:Antithrombin III